Nortis, a Seattle-area startup based in 2011 that markets “organ-on-a-chip” know-how, has raised $6 million, in keeping with an SEC submitting.
The corporate’s microfluidic chips foster the expansion of human cells in ways in which resemble organs, and have been used to create kidney, liver, blood vessel, coronary heart, gut, and tumor fashions for researchers.
Nortis has beforehand acquired backing from the Invoice & Melinda Gates Basis and collaborated on a venture to ship a kidney chip into area. Its chips are utilized in analysis research. The corporate spun out of VisionGate and is led by Thomas Neumann, a former exec at VisionGate.
We’ve reached out to the corporate for extra particulars in regards to the new funding and can replace if we hear again.